A patient with a history of bleeding disorders is found to have a deficiency of plasminogen activator inhibitor-1 (PAI-1). What would be the expected outcome?
Explanation
PAI-1 inhibits plasminogen activators, which are involved in fibrinolysis. A deficiency of PAI-1 would lead to increased fibrinolysis and an increased risk of bleeding.
Source
Hematology: Clinical Principles and Applications











